aic.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: | ||
Meta Tags
| Title | About |
| Description | This website uses About Us Technology More About Us Technology About Us Technology Arthritis Innovation Corporation (AIC) is a clinical-stage pharmaceutical company address |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 72.167.191.69 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
aic.com Valuation
|
US$1,658,300
Last updated: 2023-05-11 16:38:35
aic.com has Semrush global rank of 6,382,625. aic.com has an estimated worth of US$ 1,658,300, based on its estimated Ads revenue. aic.com receives approximately 191,343 unique visitors each day. Its web server is located in United States, with IP address 72.167.191.69. According to SiteAdvisor, aic.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,658,300 |
| Daily Ads Revenue | US$1,531 |
| Monthly Ads Revenue | US$45,923 |
| Yearly Ads Revenue | US$551,066 |
| Daily Unique Visitors | 12,757 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| aic.com. | A | 3600 | IP: 72.167.191.69 |
| aic.com. | NS | 3600 | NS Record: ns63.domaincontrol.com. |
| aic.com. | NS | 3600 | NS Record: ns64.domaincontrol.com. |
| aic.com. | MX | 3600 | MX Record: 20 mx2-us1.ppe-hosted.com. |
| aic.com. | MX | 3600 | MX Record: 10 mx1-us1.ppe-hosted.com. |
| aic.com. | TXT | 3600 | TXT Record: v=spf1 a:dispatch-us.ppe-hosted.com include:spf.protection.outlook.com -all |
| aic.com. | TXT | 3600 | TXT Record: MS=ms93828572 |
HtmlToTextCheckTime:2023-05-11 16:38:35
| About Us Technology More About Us Technology About Us Technology Arthritis Innovation Corporation (AIC) is a clinical-stage pharmaceutical company addressing unmet needs in orthopedic surgery and arthritis management. A private company founded in 2013, AIC leverages a world-class product development team located in Toronto, Canada and Denver, Colorado, and a proprietary polymer drug delivery system (BEPO®) formulated with previously marketed drugs. AIC’s first drug in clinical development, called F14, brings sustained, local delivery of the well-known NSAID, celecoxib (marketed as Celebrex) for the management of pain and inflammation after total knee replacement (TKR) surgery, as an alternative to narcotics or oral NSAIDs. In November of 2022, AIC commenced enrolment into their US multicenter Phase 3 trial studying F14 efficacy. Completed Phase 2 Study: Clinicaltrials.gov: NCT03541655 . For more information, click HERE . Ongoing Phase 3 Study: Clinicaltrials.gov: NCT05603832. For more |
HTTP Headers
HTTP/1.1 301 Moved Permanently location: https://aic.com/ Vary: Accept-Encoding Server: DPS/1.12.0 X-SiteId: 1000 Set-Cookie: dps_site_id=1000; path=/ Date: Sat, 06 Nov 2021 08:39:10 GMT Connection: keep-alive Keep-Alive: timeout=5 HTTP/2 404 content-type: text/html;charset=utf-8 content-length: 964 vary: Accept-Encoding server: DPS/1.12.0 x-siteid: 1000 set-cookie: dps_site_id=1000; path=/; secure date: Sat, 06 Nov 2021 08:39:11 GMT |
aic.com Whois Information
Domain Name: AIC.COM Registry Domain ID: 2492442_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-05-05T05:18:14Z Creation Date: 1995-05-08T04:00:00Z Registry Expiry Date: 2022-05-09T04:00:00Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS63.DOMAINCONTROL.COM Name Server: NS64.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-11-06T06:25:09Z <<< |